Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions

Area of Science:

• Biomedical Research
• Nanotechnology
• Oncology

Background:

• Anticancer therapies require precise delivery of bioactives to target sites to minimize off-target effects.
• Nanotechnology-based drug delivery systems are crucial for modifying biodistribution, tissue uptake, and pharmacokinetics of therapeutic agents.
• Controlled release from nanocarriers can significantly enhance drug efficacy.

Purpose of the Study:

• To review current information on pharmaceutical nanocarriers for cancer therapy and imaging.
• To highlight the potential of nanotechnology in revolutionizing cancer diagnosis and treatment.
• To discuss the advantages of nanocarriers in reducing cytotoxic effects and improving cancer cell targeting.

Main Methods:

• Review of existing literature on pharmaceutical nanocarriers.
• Analysis of various nanocarrier types including quantum dots, liposomes, nanotubes, nanoparticles, micelles, gold nanoparticles, carbon nanotubes, and solid lipid nanoparticles.
• Focus on applications in cancer therapy and imaging.

Main Results:

• Nanocarriers can enhance therapeutic effects through controlled release and improved targeting.
• Nanotechnology offers potential for targeted nano-medicines in treating various cancers.
• Nanocarriers reduce the cytotoxic effects of anticancer drugs compared to conventional formulations.

Conclusions:

• Nanotechnology-based drug delivery systems are vital for advancing cancer treatment.
• Various nanodevices show promise for diverse cancer therapies and diagnostics.
• Targeted delivery via nanocarriers improves efficacy and reduces side effects in cancer treatment.